Pune, India -- (SBWIRE) -- 06/29/2018 -- Intravenous Immunoglobulin (IVIg) is a sterile concentration of antibodies extracted from the plasma of thousands of people to be administered into patient's vein. The production of this solution is strictly based on guidelines established by World Health Organization (WHO) and the International Union of Immunological Societies (IUIS) which authenticates the reliability and amplifies its adoption. In the latest report published by Market Research Future (MRFR), the Global Intravenous Immunoglobulin Market will reach a valuation of over USD 8 Bn with a CAGR of ~5.9% from 2016 to 2023 (forecast period).

Initially, IVIg was used for treating thrombocytopenic purpura (ITP) in children. But, with the advancements in healthcare, it has beneficially affected patients suffering from diseases such as Kawasaki disease, lupus, Guillain-Barre syndrome, myositis, multiple sclerosis, etc. With its increasing applications, the market for IVIg is growing simultaneously. In the present era, the usage of IVIg has expanded to medicinal sectors such as neurology, hematology, immunology, nephrology, rheumatology, and, dermatology. Another factor which can propel the growth of the market is the rare visibility of any side effects from the treatment. The immediate side effects are chills, flu, etc. Serious side effects generally occur in patients who regularly undertake the medication or take high dosages. Till now, less than 5% has encountered severe side effects.

Some of the factors that can adversely affect the market growth are strict regulations, high cost, etc.

Global Intravenous Immunoglobulin (IVIg) Market - Key Players

The prolific players in intravenous immunoglobulin (IVIg) market are constantly sponsoring clinical trials to expand their product portfolios and gain an edge over other competitors. Players in the market avail of opportunities such as acquisitions, innovative collaborations, etc. to strengthen their foothold in the market.

Some of the key players in this market are: ABEONA THERAPEUTICS (US), Baxter (US), BDI Pharma (US), Biotest AG.(Germany),, China Biologic Products, Inc. (China), CSL Behring (US), Grifols Inc. (Spain), Kedrion S.p.A (us), Octapharma (Switzerland), Shire (Republic of Ireland), AND others.

Global Intravenous Immunoglobulin (IVIg) Market - Intended Audience

Intravenous Immunoglobulin (IVIg) medicines manufacturers and suppliers
Government and Independent Regulatory Authorities
Medical Research laboratories
Research and Development (R&D) Companies
Market Research and Consulting Service Providers
Potential Investors

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/3137 .

Global Intravenous Immunoglobulin (IVIg) Market - Segments

By type, the Global Market for Intravenous Immunoglobulin has been segmented into IgA, IgD, IgE, IgG, IgM.

By application, the market is segmented into chronic inflammatory demyelinating polyneuropathy (CIDP), hypogammaglobulinemia, multifocal motor neuropathy, immunodeficiency diseases, primary humoral immunodeficiency, myasthenia gravis (MG), Guillain-Barre Syndrome, Kawasaki disease, ITP, and others.

Sub segments of hypogammaglobulinemia are AGM1, AGM2, AGM3, AGM4, AGM5, AGM6.

Sub segments of immunodeficiency diseases are X-linked agammaglobulinemia (XLA), common variable immunodeficiency (CVID), severe combined immunodeficiency.

Sub segments of primary humoral Immunodeficiency are B cell (antibody) deficiencies, T cell deficiencies, combination B and T cell deficiencies, defective phagocytes, complement deficiencies, unknown (idiopathic).

Sub segments of myasthenia gravis are generalized myasthenia gravis, ocular myasthenia gravis, congenital myasthenia gravis, transient neonatal myasthenia gravis.

Sub segments of the Guillain-Barre syndrome are acute inflammatory demyelinating polyradiculoneuropathy (AIDP), miller fisher syndrome (MFS), acute motor axonal neuropathy (AMAN) and acute motor-sensory axonal neuropathy (AMSAN).

Sub segments of ITP are acute and chronic.

Global Intravenous Immunoglobulin (IVIg) Market - Regional Analysis

Among the regional segments, North America is expected to hold the largest share in the market till 2023. According to American Autoimmune Related Disease Association Inc (AARDA), 50 million autoimmune diseases were reported in 2012 alone. The exemplary advancements in the fields of healthcare in this region is one of the key drivers of the market. Some of the factors that are fueling the growth of the market are desk-bound lifestyles with minimum physical activities, consumption of sugar-rich foods, etc. which has led to increase in the number of diseases. Additionally, increased investments in clinical trials will push the market further in the coming couple of years.

The Europe region will hold the second spot owing to the outstanding growth of the market in Western Europe region. The growth can be attributed to increased incidence of diseases and widespread awareness about intravenous immunoglobulin in this region. The players in the market are investing huge sums for research & development which can augur the growth of the market. The Asia Pacific market, also, will witness significant growth due to increased awareness, rise in expenses on healthcare, growing geriatric population, etc. Lack of knowledge of these therapies and treatments will limit the growth in the African region. The Middle East possesses limited potential for growth.

To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/3137 .

Major Table of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

Continued….

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.